Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12

被引:176
作者
Yao, L
Sgadari, C
Furuke, K
Bloom, ET
Teruya-Feldstein, J
Tosato, G
机构
[1] US FDA, Ctr Biol Evaluat & Res, Div Hematol Prod, Bethesda, MD 20892 USA
[2] US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapies, Bethesda, MD 20892 USA
[3] NCI, Pathol Lab, Hematopathol Sect, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood.V93.5.1612.405a13_1612_1621
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-12 (IL-12) inhibits angiogenesis in vivo by inducing interferon-gamma (IFN-gamma) and other downstream mediators. Here, we report that neutralization of natural killer (NK) cell function with antibodies to either asialo GM1 or NK 1.1 reversed IL-12 inhibition of basic fibroblast growth factor (bFGF)-induced angiogenesis in athymic mice. By immunohistochemistry, those sites where bFGF-induced neovascularization was inhibited by IL-12 displayed accumulation of NK cells and the presence of IP-10-positive cells. Based on expression of the cytolytic mediators perforin and granzyme B, the NK cells were locally activated. Experimental Burkitt lymphomas treated locally with IL-12 displayed tumor tissue necrosis, vascular damage, and NK-cell infiltration surrounding small vessels. After activation in vitro with IL-12 NK cells from nude mice became strongly cytotoxic for primary cultures of syngeneic aortic endothelial cells. Cytotoxicity was neutralized by antibodies to IFN-gamma. These results document that NK cells are required mediators of angiogenesis inhibition by IL-12 and provide evidence that NK-cell cytotoxicity of endothelial cells is a potential mechanism by which IL-12 can suppress neovascularization.
引用
收藏
页码:1612 / 1621
页数:10
相关论文
共 53 条
[11]   PRODUCTION OF NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12) BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
DANDREA, A ;
RENGARAJU, M ;
VALIANTE, NM ;
CHEHIMI, J ;
KUBIN, M ;
ASTE, M ;
CHAN, SH ;
KOBAYASHI, M ;
YOUNG, D ;
NICKBARG, E ;
CHIZZONITE, R ;
WOLF, SF ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1387-1398
[12]   Mig and IP-10: CXC chemokines that target lymphocytes [J].
Farber, JM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 61 (03) :246-257
[13]   THE REGULATION OF BLOOD-VESSEL GROWTH BY VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
FERRARA, N ;
HEINSOHN, H ;
WALDER, CE ;
BUNTING, S ;
THOMAS, GR .
CARDIAC GROWTH AND REGENERATION, 1995, 752 :246-256
[14]   Blood vessel formation: What is its molecular basis? [J].
Folkman, J ;
DAmore, PA .
CELL, 1996, 87 (07) :1153-1155
[15]   ADMINISTRATION OF RECOMBINANT IL-12 TO NORMAL MICE ENHANCES CYTOLYTIC LYMPHOCYTE ACTIVITY AND INDUCES PRODUCTION OF IFN-GAMMA IN-VIVO [J].
GATELY, MK ;
WARRIER, RR ;
HONASOGE, S ;
CARVAJAL, DM ;
FAHERTY, DA ;
CONNAUGHTON, SE ;
ANDERSON, TD ;
SARMIENTO, U ;
HUBBARD, BR ;
MURPHY, M .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (01) :157-167
[16]   RECOMBINANT INTERLEUKIN-12 CURES MICE INFECTED WITH LEISHMANIA-MAJOR [J].
HEINZEL, FP ;
SCHOENHAUT, DS ;
RERKO, RM ;
ROSSER, LE ;
GATELY, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (05) :1505-1509
[17]   DEVELOPMENT OF TH1 CD4+ T-CELLS THROUGH IL-12 PRODUCED BY LISTERIA-INDUCED MACROPHAGES [J].
HSIEH, CS ;
MACATONIA, SE ;
TRIPP, CS ;
WOLF, SF ;
OGARRA, A ;
MURPHY, KM .
SCIENCE, 1993, 260 (5107) :547-549
[18]   Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature [J].
Huang, XM ;
Molema, G ;
King, S ;
Watkins, L ;
Edgington, TS ;
Thorpe, PE .
SCIENCE, 1997, 275 (5299) :547-550
[19]   Contribution of the CXC chemokines IF-10 and Mig to the antitumor effects of IL-12 [J].
Kanegane, C ;
Sgadari, C ;
Kanegane, H ;
Teruya-Feldstein, J ;
Yao, L ;
Gupta, G ;
Farber, JM ;
Liao, F ;
Liu, L ;
Tosato, G .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (03) :384-392
[20]   A GLYCOLIPID ON THE SURFACE OF MOUSE NATURAL-KILLER CELLS [J].
KASAI, M ;
IWAMORI, M ;
NAGAI, Y ;
OKUMURA, K ;
TADA, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1980, 10 (03) :175-180